ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Lumibird

Lumibird (LBIRD)

8.96
-0.04
(-0.44%)
Cerrado 03 Diciembre 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
8.96
Postura de Compra
8.90
Postura de Venta
9.06
Volume Operado de la Acción
13,116
8.96 Rango del Día 9.08
6.78 Rango de 52 semanas 15.48
Capitalización de Mercado [m]
Precio Anterior
9.00
Precio de Apertura
9.00
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
11,481
Acciones en circulación
22,228,377
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
35.81
Beneficio por acción (BPA)
0.32
turnover
207.91M
Beneficio neto
7.13M

Acerca de Lumibird

Sector
Electromedical Apparatus
Industria
Electromedical Apparatus
Sitio web
Sede
Saint-brieuc, Cotes-d'armor, Fra
Fundado
-
Lumibird is listed in the Electromedical Apparatus sector of the Euronext with ticker LBIRD. The last closing price for Lumibird was 9.00 €. Over the last year, Lumibird shares have traded in a share price range of 6.78 € to 15.48 €.

Lumibird currently has 22,228,377 shares in issue. The market capitalisation of Lumibird is 200.06 € million. Lumibird has a price to earnings ratio (PE ratio) of 35.81.

LBIRD Últimas noticias

LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION

LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION Lannion, November 27, 2024 – 8:00 am LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION Following market rumours, Lumibird...

LUMIBIRD : PROJET EXPLORATOIRE DE VENTE DE LA DIVISION MEDICALE

LUMIBIRD : PROJET EXPLORATOIRE DE VENTE DE LA DIVISION MEDICALE Lannion, le 27 novembre 2024– 8h00 LUMIBIRD : PROJET EXPLORATOIRE DE VENTE DE LA DIVISION MEDICALE Suite à des rumeurs de marché...

Lumibird : nombre d'actions au 31 octobre 2024

Lumibird : nombre d'actions au 31 octobre 2024      Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L.233-8 II du Code de commerce et 223-16 du...

LUMIBIRD : CHIFFRE D’AFFAIRES T3 - SIGNATURE D’UN ACCORD EN VUE DE L’ACQUISITION DE LA GAMME PRODUITS CONTINUUM AUPRÈS DU GROUPE AMPLITUDE LASER

LUMIBIRD : CHIFFRE D’AFFAIRES T3 - SIGNATURE D’UN ACCORD EN VUE DE L’ACQUISITION DE LA GAMME PRODUITS CONTINUUM AUPRÈS DU GROUPE AMPLITUDE LASER Lannion, 21 octobre 2024 – 17h55 CHIFFRE...

LUMIBIRD: Q3 REVENUE - AGREEMENT SIGNED TO ACQUIRE THE CONTINUUM PRODUCT RANGE FROM THE AMPLITUDE LASER GROUP

LUMIBIRD: Q3 REVENUE - AGREEMENT SIGNED TO ACQUIRE THE CONTINUUM PRODUCT RANGE FROM THE AMPLITUDE LASER GROUP Lannion, October 21, 2024 – 5:55 pm Q3 REVENUEAGREEMENT SIGNED TO ACQUIRE THE...

LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M

LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M Lannion, October 15, 2024 – 17:45 pm LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S...

LUMIBIRD : LES BANQUES RENOUVELLENT LEUR CONFIANCE DANS LA STRATÉGIE DU GROUPE VIA UN FINANCEMENT DE PLUS DE 100 M€

LUMIBIRD : LES BANQUES RENOUVELLENT LEUR CONFIANCE DANS LA STRATÉGIE DU GROUPE VIA UN FINANCEMENT DE PLUS DE 100 M€ Lannion, le 15 octobre 2024– 17h45 LUMIBIRD : LES BANQUES RENOUVELLENT LEUR...

Lumibird : nombre d'actions au 30 septembre 2024

Lumibird : nombre d'actions au 30 septembre 2024      Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L.233-8 II du Code de commerce et...

LUMIBIRD : Rapport financier semestriel au 30 juin 2024

LUMIBIRD : Rapport financier semestriel au 30 juin 2024 LUMIBIRD : Rapport financier semestriel au 30 juin 2024 Pièce jointe Rapport financier semestriel LMB 2024-S1-VDEF

LUMIBIRD : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2024

LUMIBIRD : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2024 Lannion, le 26 septembre 2024– 17h45 LUMIBIRD : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2024...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
11.8626.19718309867.19.67.1206399.08689819DE
41.962879.66.8122187.82941175DE
12-1.04-10.410106.78114817.76779332DE
26-3.89-30.272373540912.85136.7897509.25672043DE
52-4.16-31.707317073213.1215.486.78997111.00965475DE
156-12.14-57.535545023721.124.356.78766015.12252422DE
260-4.94-35.539568345313.924.355.41092913.89823316DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M
Stumblebum Stumblebum 2 minutos hace
Hope so I’ve been accumulating UNCY the last few months …..got a decent position and still adding here and there
UNCY
Slim6 Slim6 3 minutos hace
Crazy valuations! The cyclically adjusted (CAPE) S&P 500 PE ratio is the highest since Sept 2000. It should be 15, but is now over 38.6. Most companies are showing lower earnings than prior year. We could easily see 60% drop in stock indexes from here. #WayOvervalued
QQQ
kenjiroo kenjiroo 3 minutos hace
Hmmm Pea … As I remember … been over a year (sept 2O24) Lamar was annonced as vice president of sports and entertainment and General wharton even in 2021 as chairman … Did not see anything yet … so WHAT IN a NAME !! Doesn’t mean much to me ! Who’s next ? Taylor Swift :-)
TPTW
BigBadWolf BigBadWolf 3 minutos hace
(If...just added GTC) I know 10m of those 9s that will not be going back on the 001s
RDAR
weedtrader420 weedtrader420 3 minutos hace
Good thing Bitcoin XRP‘s American coins And Donald Trump is gonna pay down on our $35 trillion debt using cryptocurrency
XRPUSD
Golden Cross Golden Cross 3 minutos hace
$ILLR AI technology has been a Game Changer for Triller. Major
developments are happening at Triller! Way Undervalued Here!

https://www.youtube.com/watch?v=trYbvzzlWSc

[yt]trYbvzzlWSc[/yt]
ILLR
GrantHorvat1 GrantHorvat1 4 minutos hace
I'm absolutely amazed at the Doom crews amount of time and effort put on on a sub penny stock. There is a group of 4 of them that have copy and paste down to an art format.

On your persistence alone, pure insanity but definitely persistence...I salute you.

Now get ready
GVSI
Checkmate 36 Checkmate 36 4 minutos hace
Theorysuit,
God forbid we have hope in a cancer tech that can change the medical landscape. Why would someone have so much hope in something good?

…you picked the wrong co to bet against.
NWBO
1vman 1vman 4 minutos hace
***** 🚽DBMM🚽 1OK , 8K Are horrible , one look at PPS and financials confirm this - Wh👀ps

ENOUGH SAID HUZZAH🤪 !!!
DBMM
richme richme 4 minutos hace
My average is .0244 but on the losing side by a few K.
ZHUD
Green Leaf Smoker Green Leaf Smoker 4 minutos hace
Theirs a Henry Loophole in statement "Zooming on Friday" On...Which / What / Next week / Next year / 10 years from now ..FRIDAY???
PHIL
DCBill DCBill 4 minutos hace
The MBA is a major opponent of anything Fannie investors would seek!!!
The historic irony is that Fannie and later Freddie created the market for mortgage bankers years ago, allowing them to originate and sell their products.
One large issue is that efficiencies both F&F could bring to
FNMA
Lone Clone Lone Clone 4 minutos hace
Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling Program

Results continue to indicate impressive grades and ongoing potential to expand resources and replace mined reserves

https://www.newsfilecorp.com/release/232143/Torex-Gold-Reports-
TXG
art2426 art2426 4 minutos hace
>>>The MundiPharma suit is still on the table.
BIEL
branster branster 4 minutos hace
JT: https://x.com/hoffmann6383/status/1863982801550233803
NWBO
Whalatane Whalatane 5 minutos hace
Yep ..it applies to Medicare patients on dialysis . ARDX did not apply to the TDAPA process which determines pricing because CMS wants Xphozah in the dialysis bundle which would mean in about 5 yrs Xphozah would have to compete with generic pricing .
Their view is ...why spend the time and $
ARDX UNCY
dexprs dexprs 5 minutos hace
Added a little of BOW and RSI.
Bought back Covered Calls in COP 9 and LMT 2.
LMT
Klinsmann Klinsmann 5 minutos hace
This stock is going to really bust! Most don't have that needed patience...
ITRM
Risk vs Reward Risk vs Reward 6 minutos hace
Hit it hard or don't play the game !! Kudos to your intuition and conviction Sir 
KULR
TightCoil TightCoil 6 minutos hace
FNMA and FMCC
Houston Ground Control to Launch Pad - over
Houston Ground Control to Launch Pad - over
Launch Pad to Ground Control - we hear you, Ground
Houston to Launch - You are clear to Launch
High Altitude Gear Only
FMCC
ETG58 ETG58 6 minutos hace
Thank you. Appreciate the explanation
MONI
John Doe 2024 John Doe 2024 6 minutos hace
Exactly he's a straight pumper. Not a single claim he has made in 3 years along with XERI has been true.
XERI